ZA945236B - Use of N-(pyridinyl)-1H-indol-1-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders - Google Patents
Use of N-(pyridinyl)-1H-indol-1-amines for the preparation of a medicament for the treatment of obsessive-compulsive disordersInfo
- Publication number
- ZA945236B ZA945236B ZA945236A ZA945236A ZA945236B ZA 945236 B ZA945236 B ZA 945236B ZA 945236 A ZA945236 A ZA 945236A ZA 945236 A ZA945236 A ZA 945236A ZA 945236 B ZA945236 B ZA 945236B
- Authority
- ZA
- South Africa
- Prior art keywords
- preparation
- treatment
- obsessive
- indol
- pyridinyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/092,848 US5356910A (en) | 1993-07-19 | 1993-07-19 | Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorder |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA945236B true ZA945236B (en) | 1995-02-28 |
Family
ID=22235450
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA945236A ZA945236B (en) | 1993-07-19 | 1994-07-18 | Use of N-(pyridinyl)-1H-indol-1-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders |
Country Status (21)
Country | Link |
---|---|
US (1) | US5356910A (fr) |
EP (1) | EP0635269B1 (fr) |
JP (1) | JP2807633B2 (fr) |
KR (1) | KR100325276B1 (fr) |
AT (1) | ATE186215T1 (fr) |
AU (1) | AU673747B2 (fr) |
CA (1) | CA2128312C (fr) |
CZ (1) | CZ288593B6 (fr) |
DE (1) | DE69421457T2 (fr) |
DK (1) | DK0635269T3 (fr) |
EG (1) | EG20716A (fr) |
ES (1) | ES2138017T3 (fr) |
GR (1) | GR3032292T3 (fr) |
HU (1) | HU217063B (fr) |
MX (1) | MX9405209A (fr) |
NO (1) | NO306597B1 (fr) |
NZ (1) | NZ264015A (fr) |
PL (1) | PL304335A1 (fr) |
RU (1) | RU2164795C2 (fr) |
TW (1) | TW349864B (fr) |
ZA (1) | ZA945236B (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5459274A (en) * | 1994-05-13 | 1995-10-17 | Hoechst-Roussel Pharmaceuticals Inc. | Preparation of N-alkyl-N-pyridinyl-1H-indol-1-amines |
CN1184969C (zh) * | 1995-07-27 | 2005-01-19 | 阿温蒂斯药物公司 | 未取代和取代的n-(吡咯-1-基)吡啶胺作为抗惊厥药的用途 |
HUP9802413A3 (en) * | 1995-07-27 | 2002-02-28 | Aventis Pharmaceuticals Inc Br | Use of n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents and for the preparation of a pharmaceutical composition for the treatment of convulsions |
JP4608723B2 (ja) * | 1999-03-10 | 2011-01-12 | 東ソー株式会社 | 置換インドール誘導体の製造方法 |
GT200500063A (es) * | 2004-04-01 | 2005-10-14 | Metodo para tratar la esquizofrenia y/o anormalidades glucoregulatorias | |
FR2892022B1 (fr) * | 2005-10-19 | 2008-01-04 | Urogene Sa | Traitement des symptomes de l'irritation de la vessie |
FR2892021B1 (fr) * | 2005-10-19 | 2008-01-04 | Urogene | Traitement de l'incontinence urinaire d'effort et mixte |
FR2897614B1 (fr) * | 2006-02-20 | 2008-05-23 | Urogene | Forme cristalline du chlorhydrate de la besipirdine, procedes de preparation et utilisations |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4970218A (en) * | 1987-04-24 | 1990-11-13 | Hoechst-Roussel Pharmaceuticals Inc. | N-(pyridinyl)-1H-indol-1-amines |
US4880822A (en) * | 1987-04-24 | 1989-11-14 | Hoechst-Roussel Pharmaceuticals, Inc. | N-(pyridinyl)-1H-indol-1-amines |
DE3852335T2 (de) | 1987-04-24 | 1995-05-11 | Hoechst Roussel Pharma | N-(Pyridinyl)-1H-indol-1-amine, Verfahren zu deren Herstellung und ihre Verwendung als Arzneimittel. |
US5179099A (en) * | 1989-08-02 | 1993-01-12 | Hoechst-Roussel Pharmaceuticals Incorporated | 2,3-dihydro-1-(pyridinylamino)-indoles |
US5214038A (en) * | 1991-04-15 | 1993-05-25 | Hoechst-Roussel Pharmaceuticals Inc. | 1-(pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1H-indoles and intermediates for the preparation thereof |
US5177088A (en) * | 1991-04-17 | 1993-01-05 | Hoechst-Roussel Pharmaceuticals Incorporated | Substituted 3-(pyridinylamino)-indoles |
US5185350A (en) | 1991-09-23 | 1993-02-09 | Hoechst-Roussel Pharmaceuticals Incorporated | Substituted pyridinylamino-1h-indoles,1h-indazoles,2h-indazoles, benzo (b)thiophenes and 1,2-benzisothiazoles |
-
1993
- 1993-07-19 US US08/092,848 patent/US5356910A/en not_active Expired - Lifetime
-
1994
- 1994-07-04 TW TW083106064A patent/TW349864B/zh not_active IP Right Cessation
- 1994-07-08 MX MX9405209A patent/MX9405209A/es unknown
- 1994-07-12 EG EG417094A patent/EG20716A/xx active
- 1994-07-13 ES ES94110875T patent/ES2138017T3/es not_active Expired - Lifetime
- 1994-07-13 DE DE69421457T patent/DE69421457T2/de not_active Expired - Lifetime
- 1994-07-13 AT AT94110875T patent/ATE186215T1/de active
- 1994-07-13 EP EP94110875A patent/EP0635269B1/fr not_active Expired - Lifetime
- 1994-07-13 DK DK94110875T patent/DK0635269T3/da active
- 1994-07-15 AU AU67531/94A patent/AU673747B2/en not_active Expired
- 1994-07-15 NZ NZ264015A patent/NZ264015A/en not_active IP Right Cessation
- 1994-07-18 RU RU94026084/14A patent/RU2164795C2/ru active
- 1994-07-18 JP JP6165280A patent/JP2807633B2/ja not_active Expired - Lifetime
- 1994-07-18 PL PL94304335A patent/PL304335A1/xx unknown
- 1994-07-18 NO NO942695A patent/NO306597B1/no not_active IP Right Cessation
- 1994-07-18 KR KR1019940017236A patent/KR100325276B1/ko not_active IP Right Cessation
- 1994-07-18 HU HU9402124A patent/HU217063B/hu unknown
- 1994-07-18 ZA ZA945236A patent/ZA945236B/xx unknown
- 1994-07-18 CA CA002128312A patent/CA2128312C/fr not_active Expired - Lifetime
- 1994-07-18 CZ CZ19941730A patent/CZ288593B6/cs not_active IP Right Cessation
-
1999
- 1999-12-30 GR GR990403380T patent/GR3032292T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
PL304335A1 (en) | 1995-01-23 |
HUT69709A (en) | 1995-09-28 |
KR950002761A (ko) | 1995-02-16 |
US5356910A (en) | 1994-10-18 |
RU2164795C2 (ru) | 2001-04-10 |
HU9402124D0 (en) | 1994-09-28 |
NZ264015A (en) | 1997-07-27 |
EP0635269B1 (fr) | 1999-11-03 |
DK0635269T3 (da) | 2000-04-25 |
CZ173094A3 (en) | 1995-02-15 |
NO942695D0 (no) | 1994-07-18 |
MX9405209A (es) | 1995-01-31 |
CA2128312C (fr) | 2004-09-28 |
RU94026084A (ru) | 1996-08-27 |
GR3032292T3 (en) | 2000-04-27 |
JP2807633B2 (ja) | 1998-10-08 |
AU673747B2 (en) | 1996-11-21 |
NO306597B1 (no) | 1999-11-29 |
KR100325276B1 (ko) | 2002-09-25 |
DE69421457D1 (de) | 1999-12-09 |
ATE186215T1 (de) | 1999-11-15 |
DE69421457T2 (de) | 2000-05-04 |
TW349864B (en) | 1999-01-11 |
EP0635269A1 (fr) | 1995-01-25 |
HU217063B (hu) | 1999-11-29 |
NO942695L (no) | 1995-01-20 |
EG20716A (en) | 1999-12-29 |
CA2128312A1 (fr) | 1995-01-20 |
AU6753194A (en) | 1995-01-27 |
ES2138017T3 (es) | 2000-01-01 |
JPH0753376A (ja) | 1995-02-28 |
CZ288593B6 (cs) | 2001-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL127244A0 (en) | Pharmaceutical for treatment of neurological and neuropsychiatric disorders | |
HU9600834D0 (en) | Quinazoline derivatives | |
TR200000129T2 (tr) | Yepyeni spiroazabisiklik heterosiklik bileşikler. | |
PL314086A1 (en) | Novel (r)-8-fluoro-3-n,n-substituted amino 3,4-dihydro 5-carbamoyl-2h-1-bezopyranes | |
AP9701041A0 (en) | Pyridylpyrrole compounds. | |
AU5752194A (en) | Benzimidazole compounds, their use and preparation | |
JO1613B1 (en) | Derivatives of n - (3-hydroxy-4-piperidnil) dihydrobenzofuran, dihydro-2u-benzopyran or dihydro-benzodoxine) carboxymide | |
MXPA04000278A (es) | Uso de antagonistas del receptor nk-1 con estructura piridinica para tratamiento de lesiones cerebrales, espinales o neuronales. | |
WO1999012532A3 (fr) | Derives de piperidine contre la malaria | |
WO1997005862A3 (fr) | Utilisation des aminoacides de base et de leurs derives pour abaisser les taux de ceramide | |
HU9402124D0 (en) | Use of n-(pyridinyl)-1h-indoll-1-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders | |
CA2282279A1 (fr) | Atropisomeres de 3-heteroaryl-4(3h)-quinazolinones pour le traitement des troubles neurodegeneratifs et des troubles lies a un traumatisme du systeme nerveux central | |
TW285640B (fr) | ||
SE9702716D0 (sv) | Substituted phenylazacycloalkanes in the treatment of cognitive disorders | |
GB8823605D0 (en) | Therapeutic agents | |
AU6046096A (en) | Methods of treating microbial infections | |
HRP20030696A2 (en) | GlyT-1 INHIBITORS | |
WO1994016705A3 (fr) | Composition pharmaceutique contenant de la 5-morpholinomethyle-3-(4-chlorobenzylideneamine)-2-oxazolidinone et son utilisation pour le traitement des troubles du snc |